Back

External validation of the RAISE score for the diagnosis of transthyretin-related cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Cardiac amyloidosis (2) Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Alvaro Roldan Guerra

Reina Sofia University Hospital, Cordoba (Spain)

9 More presentations in this session

Presentation thumbnail
Discussant - Cardiac amyloidosis (2)
Presentation thumbnail
Right ventricular-pulmonary arterial coupling and outcomes in cardiac amyloidosis: Systematic review and meta-analysis
Doctor A. Sakalidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Diagnostic yield of scintigraphy in suspected cardiac amyloidosis without left ventricular hypertrophy
Doctor N. Mora Ayestaran (Pamplona, Navarra, ES)
Abstract Slides Video
Presentation thumbnail
Early symptoms and medical history of patients with transthyretin amyloidosis cardiomyopathy: Results from the multi-country OverTTuRe study
Professor J. Smith (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Effectiveness and safety of edge-to-edge MItral vaLve repair in patients with significant mitraL rEgurgitatioN aNd cardIac ATTR amyloidosis: design and rationale of the MILLENNIAL trial
Doctor L. Hauptmann (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Cardiac amyloidosis (2)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources